Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD4+ CCR7+ Depletion in HSC Allograft
NCT03280290Completed
- Sponsor
- CHU de Lille
- Start
- Mar 2012
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU de Lille. Primary endpoints: Change the lymphocyte proliferation at 8 days and Change the functional properties of cells at 8 days. Started Mar 2012; status: completed.
Beyond the preview
Go deeper on NCT03280290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03280290.